S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory

Hepatology

Volumn 47, Issue 2, 2008, Pages 613-624

  Li, Jun ^a   Bardag Gorce, Fawzia ^a   Dedes, Jennifer ^a   French, Barbara Alan ^a   Amidi, Fataneh ^a   Oliva, Joan ^a   French, Samuel William ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER; ALPHA FETOPROTEIN; EARLY GROWTH RESPONSE FACTOR 2; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE PEROXIDASE 2; GLUTATHIONE TRANSFERASE M2; HISTONE DEACETYLASE 9; INTERLEUKIN 9; KRUPPEL LIKE FACTOR 6; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOSE TIME EFFECT RELATION; GENE EXPRESSION REGULATION; IMMUNOLOGICAL MEMORY; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LIVER CELL; MALE; MALLORY BODY; MALLORY DENK BODY; MOLECULAR MODEL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRECANCER; PRIORITY JOURNAL;

ALDEHYDES; ANIMALS; INCLUSION BODIES; LIVER; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED C3H; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; S-ADENOSYLMETHIONINE; ZALCITABINE;

EID: 39549103864     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22029     Document Type: Article

References (34)

1. Zatloukal K, French SW, Stumptner C, Strnad P, Harada M, Toivola DM, et al. From Mallory to Mallory-Denk bodies: what, how and why? Exp Cell Res 2007;313:2033-2049.
2. French BA, van Leeuwen F, Riley NE, Yuan QX, Bardag-Gorce F, Lue YH. Aggresome formation in liver cells in response to different toxic mechanisms. Role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin. Exp Mol Pathol 2001;71:241-246.
3. Riley NE, Li J, McPhaul L, Lue Y, French SW. Heat shock proteins and Mallory bodies (cytokeratin aggresomes) in human liver biopsies. Exp Mol Pathol 2003;74:168-174.
4. Zhang-Gouillon ZQ, Yuan QX, Hu B, Gaal K, Marceau N, French SW. Alcohol induces Mallory body formation in drug-primed mice. HEPATOLOGY 1998;27:116-122.
5. Yuan Q, Nagao Y, Wan Y, Hu B, Gaal K, French BA, et al. Mechanisms of Mallory body formation induced by okadaic acid in drug primed mice. Exp Mol Pathol 1998;65:87-103.
6. Purohit V, Abdelmalek MF, Barve S, Benevenga NJ, Halsted CH, Kaplowitz, et al. Role of S-adenosylinethione, folate, and betamine in the treatment of alcoholic liver disease: summary of a symposium. Am J Clin Nutr 2007;86:14-24.
7. Nan L, Dedes J, French BA, Bardag-Gorce F, Li J, Wu Y. Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor. Exp Mol Pathol 2006;80:228-240.
8. Nan L, Wu Y, Bardag-Gorce F, Li J, French BA, Wilson LT. The p105/50 NF-κB pathway is essential for Mallory body formation. Exp Mol Pathol 2005;78:198-206.
9. Wu Y, Nan L, Bardag-Gorce F, Li J, French BA, Wilson LT. The role of the laminin-integrated signaling in triggering MB formation. An in vivo and in vitro study. Exp Mol Pathol 2005;79:1-8.
10. Yuan QX, Marceau N, French BA, Fu P, French SW. Mallory body induction in drug-primed mouse liver. HEPATOLOGY 1996;24:603-612.
11. Bardag-Gorce F, Dedes J, French BA, Oliva J, Li J, French SW. Mallory body formation is associated with epigenetic phenotypic change in hepatocytes in vivo. Exp Mol Pathol 2007;3:160-168.
12. Reilly NE, Bardag-Gorce F, Montgomery RO, Li J, Lungo W, Lue YH, et al. Microtubules are required for cytokeratin aggresomes (Mallory body) formation in hepatocytes: an in vitro study. Exp Mol Pathol 2003;74:173-179.
13. Simon MD, Chu F, Racki LR, dela Cruz CC, Burlingame AL, Panning B, et al. The site-specific installation of methyl lysine analogs into recombinant histones. Cell 2007;128:1003-1012.
14. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC, et al. Active genes are tri-methylated at k4 of histone H3. Nature 2002;419:407-411.
15. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
16. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994;233:346-357.
17. Denk H. Rearrangement of the hepatocyte cytoskeleton after toxic damage: involution, dispersal and peripheral accumulation of Mallory body material after drug withdrawal. Eur J Cell Biol 1981;23:241-249.
18. Nan L, Wu Y, Bardag-Gorce F, Li J, French BA, Fu AN, et al. p62 is involved in the mechanism of Mallory body formation. Exp Mol Pathol 2004;77:168-175.
19. Stumptner C, Fuchobickler A, Heid H, Zatloukal K, Denk H. Mallory body - a disease-associated type of sequestrome. HEPATOLOGY 2002;35:1053-1062.
20. Zatloukal K, Stumptrer C, Fricksbickler A, Heid H, Schnoelzer M, Kenner L, et al. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002;160:255-263.
21. Nan L, Bardag-Gorce F, Wu Y, Li J, French BA, French SW. Mallory body forming cells express the preneoplastic hepatocyte phenotype. Exp Mol Pathol 2006;80:109-118.
22. Roomi MW, Gaal K, Yuan QX, French BA, Fu P, Bardag-Gorce F, et al. Preneoplastic liver cell foci expansion induced by thiacetamide toxicity in drug-primed liver. Exp Mol Pathol 2006;81:8-14.
23. Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL, Yong Tan S, et al. Expression of the FAT10 gene is highly up regulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 2003;22:2592-2603.
24. Ren J, Kan A, Leong SH, Ooi LLPJ, Jeang K-T, Chong SS, et al. Fat 10 plays a role in the regulation of chromosomal stability. J Biol Chem 2006;281:11413-11421.
25. Song J, Kim CJ, Cho YG, Kim SY, Nam SW, Lee SH, et al. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma. Gastroenterol Hepatol 2006;21:1286-1289.
26. Sirach E, Bureau C, Peron JM, Pradyrol L, Vinel JP, Buscall L, et al. KLF6 transcription factor protects hepatocellular carcinoma derived cells from apoptosis. Cell Death Differ 2007;4:1202-1210.
27. Wu D, Cederbaum AI. Opposite action of S-adenosyl methionine and its metabolites on CYP2E1-mediated toxicity in pyrazole-induced rat hepatocytes and HepG2 E47 cells. Am J Physiol Gastrointest Liver Physiol 2006;290:G674-G684.
28. Caro AA, Cederbaum AI. Antioxidant properties of S-adenosyl-L-methionine in Fe(2+)-initiated oxidations. Free Radic Biol Med 2004;36:1303-1316.
29. Lu SC, Gukovsky I, Lugea A, Reyes CN, Huang Z-Z, Chen L, et al. The role of S-adenosylmethionine in two experimental models of pancreatitis. FASEB J 2003;17:56-58.
30. Sasaki Y. Does oxidative stress participate in the development of hepatocellular carcinoma? J Gastroenterol 2006;41:1135-1148.
31. Ou J-N, Torrisani J, Onterberger A, Provencal N, Shikini K, Karimi M, et al. Histone deacetylase inhibitor trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. Biochem Pharmacol 2007;73:1297-1307.
32. Pascale RM, Simile MM, DeMiglio MR, Feo F. Chemoprevention of hepatocarcinogenesis: S-adenosyl-methionine. Alcohol 2002;27:193-198.
33. Nakanuma Y, Ohta G. Is Mallory body formation a preneoplastic change? A study of 181 cases of liver hepatocellular carcinoma and 82 cases of cirrhosis. Cancer 1985;55:2400-2404.
34. Tazawa J, Irie T, French SW. Mallory body formation runs parallel to gamma glutamyl transferase induction in hepatocytes of griseofulvin fed mice. HEPATOLOGY 1983;3:989-1001.